代谢功能障碍与遗传风险因素在非酒精性脂肪性肝病发病中的不同作用
研究纳入846人,其中492例肥胖患者有肝组织学,354人经质子磁共振波谱测肝内甘油三酯。计算PNPLA3、TM6SF2、MBOAT7、HSD17B13和MARC1风险等位基因遗传风险评分,并以血清NMR代谢组学评估底物浓度。结果显示代谢成分以底物过剩为特征,遗传成分无底物过剩但肝线粒体 redox 状态升高,两者机制根本不同。
要点
- 代谢成分特征为28种血清代谢物升高、NEFA及其通量增加、DNL增加。
- 遗传成分不伴底物过剩,但肝线粒体 redox 状态升高且DNL受抑制。
- 血清β-羟丁酸/乙酰乙酸比值与NAFLD所有组织学特征强相关。
核心结论
- NAFLD的代谢成分与遗传成分机制根本不同,代谢成分以底物过剩为特征,遗传成分以肝线粒体功能受损为特征。
研究设计与样本
- 研究共纳入846人,其中492例为有肝组织学的肥胖患者,354人经质子磁共振波谱测量肝内甘油三酯。
- 遗传风险评分基于PNPLA3、TM6SF2、MBOAT7、HSD17B13和MARC1的风险等位基因数量计算。
- 在部分参与者中,通过D5-甘油和 hyperinsulinemic-euglycemic clamp 评估非酯化脂肪酸及其通量(n=41),通过D2O测量肝脏从头脂肪生成(n=61)。
主要发现
- 代谢成分表现为28种血清代谢物(包括葡萄糖、糖酵解中间产物和氨基酸)浓度升高、NEFA及其通量增加、DNL增加。
- 遗传成分不伴随任何底物过剩,但以血清β-羟丁酸/乙酰乙酸比值升高的肝线粒体 redox 状态升高为特征,并抑制依赖三羧酸循环活性的肝脏通路如DNL。
- 血清β-羟丁酸/乙酰乙酸比值与NAFLD所有组织学特征强相关。
- 胰岛素抵抗和肝线粒体 redox 状态对NAFLD组织学特征产生叠加性增加。
临床怎么用
- 这些发现可能对NAFLD的诊断和治疗有启示意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There is substantial inter-individual variability in the risk of non-alcoholic fatty liver disease (NAFLD). Part of which is explained by insulin resistance (IR) ('MetComp') and part by common modifiers of genetic risk ('GenComp'). We examined how IR on the one hand and genetic risk on the other contribute to the pathogenesis of NAFLD. METHODS: We studied 846 individuals: 492 were obese patients with liver histology and 354 were individuals who underwent intrahepatic triglyceride measurement by proton magnetic resonance spectroscopy. A genetic risk score was calculated using the number of risk alleles in PNPLA3, TM6SF2, MBOAT7, HSD17B13 and MARC1. Substrate concentrations were assessed by serum NMR metabolomics. In subsets of participants, non-esterified fatty acids (NEFAs) and their flux were assessed by D5-glycerol and hyperinsulinemic-euglycemic clamp (n = 41), and hepatic de novo lipogenesis (DNL) was measured by D2O (n = 61). RESULTS: We found that substrate surplus (increased concentrations of 28 serum metabolites including glucose, glycolytic intermediates, and amino acids; increased NEFAs and their flux; increased DNL) characterized the 'MetComp'. In contrast, the 'GenComp' was not accompanied by any substrate excess but was characterized by an increased hepatic mitochondrial redox state, as determined by serum β-hydroxybutyrate/acetoacetate ratio, and inhibition of hepatic pathways dependent on tricarboxylic acid cycle activity, such as DNL. Serum β-hydroxybutyrate/acetoacetate ratio correlated strongly with all histological features of NAFLD. IR and hepatic mitochondrial redox state conferred additive increases in histological features of NAFLD. CONCLUSIONS: These data show that the mechanisms underlying 'Metabolic' and 'Genetic' components of NAFLD are fundamentally different. These findings may have implications with respect to the diagnosis and treatment of NAFLD. LAY SUMMARY: The pathogenesis of non-alcoholic fatty liver disease can be explained in part by a metabolic component, including obesity, and in part by a genetic component. Herein, we demonstrate that the mechanisms underlying these components are fundamentally different: the metabolic component is characterized by hepatic oversupply of substrates, such as sugars, lipids and amino acids. In contrast, the genetic component is characterized by impaired hepatic mitochondrial function, making the liver less able to metabolize these substrates.
引用
- Luukkonen PK, Qadri S, Ahlholm N, et al. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2021. PMID: 34710482. doi:10.1016/j.jhep.2021.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。